Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
Clinical trial NCT03341845 · UNKNOWN
Trial details
- NCT number
- NCT03341845
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2023-01-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.